Rhythm Pharmaceuticals Inc (RYTM)
38.52
+0.38
(+0.98%)
USD |
NASDAQ |
Apr 26, 12:48
Rhythm Pharmaceuticals Cash and Short Term Investments (Quarterly): 275.85M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 275.85M |
| September 30, 2023 | 299.26M |
| June 30, 2023 | 253.60M |
| March 31, 2023 | 294.58M |
| December 31, 2022 | 333.29M |
| September 30, 2022 | 347.80M |
| June 30, 2022 | 235.60M |
| March 31, 2022 | 240.96M |
| December 31, 2021 | 294.86M |
| September 30, 2021 | 328.35M |
| June 30, 2021 | 368.15M |
| March 31, 2021 | 404.75M |
| December 31, 2020 | 172.79M |
| September 30, 2020 | 201.78M |
| Date | Value |
|---|---|
| June 30, 2020 | 228.63M |
| March 31, 2020 | 257.42M |
| December 31, 2019 | 292.46M |
| September 30, 2019 | 162.44M |
| June 30, 2019 | 195.17M |
| March 31, 2019 | 221.52M |
| December 31, 2018 | 252.06M |
| September 30, 2018 | 272.39M |
| June 30, 2018 | 287.55M |
| March 31, 2018 | 136.45M |
| December 31, 2017 | 148.08M |
| September 30, 2017 | 30.42M |
| June 30, 2017 | 38.22M |
| December 31, 2016 | 10.54M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
162.44M
Minimum
Sep 2019
404.75M
Maximum
Mar 2021
273.04M
Average
275.85M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Pfizer Inc | 12.69B |
| Insmed Inc | 780.45M |
| Altimmune Inc | 197.82M |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Viking Therapeutics Inc | 962.98M |